These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 28587390

  • 1. MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2.
    Feng Q, Wu Q, Liu X, Xiong Y, Li H.
    Exp Ther Med; 2017 Jun; 13(6):3167-3174. PubMed ID: 28587390
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.
    Wu Q, Zhou W, Feng Q, Liu X, Xiong Y, Li H.
    Exp Ther Med; 2018 Jan; 15(1):173-181. PubMed ID: 29250147
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ.
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [Abstract] [Full Text] [Related]

  • 5. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.
    Zhang Y, Wang J, An W, Chen C, Wang W, Zhu C, Chen F, Chen H, Zheng W, Gong J.
    Technol Cancer Res Treat; 2019 Mar; 18():1533033819854132. PubMed ID: 31138033
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.
    Wang Z, He R, Xia H, Wei YU, Wu S.
    Exp Ther Med; 2016 Apr; 11(4):1293-1299. PubMed ID: 27073439
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R, Wu SN, Gao CC, Yang XZ, Wang HG, Zhang JL, Yan W, Ma TH.
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG, Tang QL, Wei JH, He FY, Lu L, Tang YJ.
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F, Zhang Z, Zhang X.
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
    Huang HG, Tang XL, Huang XS, Zhou L, Hao YG, Zheng YF.
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
    [Abstract] [Full Text] [Related]

  • 16. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J, Xu Y, Tao L, Pan Y, Zhang K, Wang R, Chen LB, Chu X.
    Cell Physiol Biochem; 2017 Apr; 41(2):583-597. PubMed ID: 28214878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma.
    Liu D, Zhang C, Li X, Zhang H, Pang Q, Wan A.
    EXCLI J; 2018 Apr; 17():102-112. PubMed ID: 29743851
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760.
    Yuan J, Liu Y, Zhang Q, Ren Z, Li G, Tian R.
    Cancer Manag Res; 2021 Apr; 13():4433-4445. PubMed ID: 34103997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.